Sign in
Incorporating Fecal Calprotectin in Clinical Practice for Patients with Moderate to Severely Active Ulcerative Colitis Treated with Biologics or Small Molecule Inhibitors
Journal article   Peer reviewed

Incorporating Fecal Calprotectin in Clinical Practice for Patients with Moderate to Severely Active Ulcerative Colitis Treated with Biologics or Small Molecule Inhibitors

Parambir S. Dulai, Robert Battat, Maria Barsky, Nghia H. Nguyen, Christopher Ma, Neeraj Narula, Mahmoud Mosli, Niels Vande Casteele, Brigid S. Boland, Larry Prokop, …
The American journal of gastroenterology, Vol.115(6), pp.885-894
01/06/2020
PMID: 32384283

Abstract

Biomarker calprotectin monitoring treat-to-target

Details